Table 3 CMV infection during pregnancy and gestational outcomes, by prepericonceptional serostatus
| Â | Pre/periconceptional serostatus | All | P value | |
|---|---|---|---|---|
Seropositive | Seronegative | |||
| Â | 76,075 (90%) | 8035 (10%) | 84,110 | Â |
Live birth | 90.2% | 90.8% | 90.30% | 0.113 |
Abortion/TOP | 9.8% | 9.2% | 9.70% | Â |
By CMV infection | ||||
CMV infection | 0.2% | 10.3% | 1.2% |  < 0.001 |
Live birth | 90.8% | 91.6% | 91.5% | 0.768 |
Abortion/TOP | 9.2% | 8.4% | 8.5% | Â |
No CMV infection | 99.8% | 89.7% | 98.8% | 0.209 |
Live birth | 90.2% | 90.7% | 90.3% | Â |
Abortion/TOP | 9.8% | 9.3% | 9.7% | Â |